Previous Article | Next Article 
Molecular and Cellular Biology, April 2003, p. 2341-2350, Vol. 23, No. 7
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.7.2341-2350.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Transcription-Dependent Degradation of Topoisomerase I-DNA Covalent Complexes
Shyamal D. Desai,1 Hui Zhang,2 Alexandra Rodriguez-Bauman,1 Jin-Ming Yang,3 Xiaohua Wu,3 Murugesan K. Gounder,3 Eric H. Rubin,3 and Leroy F. Liu1*
Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854,1
Department of Genetics, Yale University, New Haven, Connecticut 06520,2
Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 089013
Received 24 October 2002/
Returned for modification 14 December 2002/
Accepted 7 January 2003
Topoisomerase I (Top I)-DNA covalent complexes represent a unique type of DNA lesion whose repair and processing remain unclear. In this study, we show that Top I-DNA covalent complexes transiently arrest RNA transcription in normal nontransformed cells. Arrest of RNA transcription is coupled to activation of proteasomal degradation of Top I and the large subunit of RNA polymerase II. Recovery of transcription occurs gradually and depends on both proteasomal degradation of Top I and functional transcription-coupled repair (TCR). These results suggest that arrest of the RNA polymerase elongation complex by the Top I-DNA covalent complex triggers a 26S proteasome-mediated signaling pathway(s) leading to degradation of both Top I and the large subunit of RNA polymerase II. We propose that proteasomal degradation of Top I and RNA polymerase II precedes repair of the exposed single-strand breaks by TCR.
* Corresponding author. Mailing address: Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes La., Piscataway, NJ 08854. Phone: (732) 235-4592. Fax: (732) 235-4073. E-mail:
lliu{at}umdnj.edu.
Molecular and Cellular Biology, April 2003, p. 2341-2350, Vol. 23, No. 7
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.7.2341-2350.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Baranello, L., Bertozzi, D., Fogli, M. V., Pommier, Y., Capranico, G.
(2009). DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1{alpha} gene locus. Nucleic Acids Res
0: gkp817v2-gkp817
[Abstract]
[Full Text]
-
Lin, C.-P., Ban, Y., Lyu, Y. L., Liu, L. F.
(2009). Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks. J. Biol. Chem.
284: 28084-28092
[Abstract]
[Full Text]
-
Pfister, T. D., Reinhold, W. C., Agama, K., Gupta, S., Khin, S. A., Kinders, R. J., Parchment, R. E., Tomaszewski, J. E., Doroshow, J. H., Pommier, Y.
(2009). Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Molecular Cancer Therapeutics
8: 1878-1884
[Abstract]
[Full Text]
-
Kurtzberg, L. S., Battle, T., Rouleau, C., Bagley, R. G., Agata, N., Yao, M., Schmid, S., Roth, S., Crawford, J., Krumbholz, R., Ewesuedo, R., Yu, X.-J., Wang, F., LaVoie, E. J., Teicher, B. A.
(2008). Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Molecular Cancer Therapeutics
7: 3212-3222
[Abstract]
[Full Text]
-
Lin, C.-P., Ban, Y., Lyu, Y. L., Desai, S. D., Liu, L. F.
(2008). A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes. J. Biol. Chem.
283: 21074-21083
[Abstract]
[Full Text]
-
Desai, S. D., Wood, L. M., Tsai, Y.-C., Hsieh, T.-S., Marks, J. R., Scott, G. L., Giovanella, B. C., Liu, L. F.
(2008). ISG15 as a novel tumor biomarker for drug sensitivity. Molecular Cancer Therapeutics
7: 1430-1439
[Abstract]
[Full Text]
-
Zhang, A., Lyu, Y. L., Lin, C.-P., Zhou, N., Azarova, A. M., Wood, L. M., Liu, L. F.
(2006). A Protease Pathway for the Repair of Topoisomerase II-DNA Covalent Complexes. J. Biol. Chem.
281: 35997-36003
[Abstract]
[Full Text]
-
Pond, C. D., Marshall, K. M., Barrows, L. R.
(2006). Identification of a small topoisomerase I-binding peptide that has synergistic antitumor activity with 9-aminocamptothecin.. Molecular Cancer Therapeutics
5: 739-745
[Abstract]
[Full Text]
-
Interthal, H., Chen, H. J., Champoux, J. J.
(2005). Human Tdp1 Cleaves a Broad Spectrum of Substrates, Including Phosphoamide Linkages. J. Biol. Chem.
280: 36518-36528
[Abstract]
[Full Text]
-
Tomicic, M. T., Christmann, M., Kaina, B.
(2005). Topotecan-Triggered Degradation of Topoisomerase I Is p53-Dependent and Impacts Cell Survival. Cancer Res.
65: 8920-8926
[Abstract]
[Full Text]
-
Adachi, N., So, S., Koyama, H.
(2004). Loss of Nonhomologous End Joining Confers Camptothecin Resistance in DT40 Cells: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE I-MEDIATED DNA DAMAGE. J. Biol. Chem.
279: 37343-37348
[Abstract]
[Full Text]
-
Bendetz-Nezer, S., Gazit, A., Priel, E.
(2004). DNA Topoisomerase I As One of the Cellular Targets of Certain Tyrphostin Derivatives. Mol. Pharmacol.
66: 627-634
[Abstract]
[Full Text]
-
Christensen, M. O., Krokowski, R. M., Barthelmes, H. U., Hock, R., Boege, F., Mielke, C.
(2004). Distinct Effects of Topoisomerase I and RNA Polymerase I Inhibitors Suggest a Dual Mechanism of Nucleolar/Nucleoplasmic Partitioning of Topoisomerase I. J. Biol. Chem.
279: 21873-21882
[Abstract]
[Full Text]
-
Fiorani, P., Reid, R. J. D., Schepis, A., Jacquiau, H. R., Guo, H., Thimmaiah, P., Benedetti, P., Bjornsti, M.-A.
(2004). The Deubiquitinating Enzyme Doa4p Protects Cells from DNA Topoisomerase I Poisons. J. Biol. Chem.
279: 21271-21281
[Abstract]
[Full Text]
-
Daroui, P., Desai, S. D., Li, T.-K., Liu, A. A., Liu, L. F.
(2004). Hydrogen Peroxide Induces Topoisomerase I-mediated DNA Damage and Cell Death. J. Biol. Chem.
279: 14587-14594
[Abstract]
[Full Text]
-
Yung, T. M. C., Parent, M., Ho, E. L. Y., Satoh, M. S.
(2004). Camptothecin-sensitive Relaxation of Supercoiled DNA by the Topoisomerase I-like Activity Associated with Poly(ADP-ribose) Polymerase-1. J. Biol. Chem.
279: 11992-11999
[Abstract]
[Full Text]
-
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R. H., Melillo, G.
(2004). Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1: Mechanism and Therapeutic Implications. Cancer Res.
64: 1475-1482
[Abstract]
[Full Text]
-
Zhang, H.-F., Tomida, A., Koshimizu, R., Ogiso, Y., Lei, S., Tsuruo, T.
(2004). Cullin 3 Promotes Proteasomal Degradation of the Topoisomerase I-DNA Covalent Complex. Cancer Res.
64: 1114-1121
[Abstract]
[Full Text]
-
Li, T.-K., Houghton, P. J., Desai, S. D., Daroui, P., Liu, A. A., Hars, E. S., Ruchelman, A. L., LaVoie, E. J., Liu, L. F.
(2003). Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug. Cancer Res.
63: 8400-8407
[Abstract]
[Full Text]
-
Soe, K., Grosse, F.
(2003). p53 stimulates human topoisomerase I activity by modulating its DNA binding. Nucleic Acids Res
31: 6585-6592
[Abstract]
[Full Text]